Advisor Group’s Tandem Diabetes Care TNDM Stock Holding History

Advisor Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$89K	Sell	1,507 -1,942	-56%	-$120K	﹤0.01%	3023
2019 Q3	$203K	Buy	3,449 +216	+7%	+$13.8K	﹤0.01%	2322
2019 Q2	$209K	Sell	3,233 -14,476	-82%	-$934K	﹤0.01%	2279
2019 Q1	$1.12M	Buy	17,709 +15,358	+653%	+$807K	0.01%	1013
2018 Q4	$89K	Buy	2,351 +650	+38%	+$23K	﹤0.01%	2736
2018 Q3	$73K	Buy	1,701 +1,226	+258%	+$42.8K	﹤0.01%	2992
2018 Q2	$10K	Sell	475 -525	-53%	-$6.46K	﹤0.01%	4081
2018 Q1	$5K	Buy	1,000 +900	+900%	+$2.9K	﹤0.01%	4430
2017 Q4	$0	Hold	100	–	–	﹤0.01%	5065
2017 Q3	$1K	Hold	100	–	–	﹤0.01%	4727
2017 Q2	$1K	Hold	100	–	–	﹤0.01%	4677
2017 Q1	$1K	Buy	+100	New	+$2.19K	﹤0.01%	4584

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Advisor Group's TNDM Position: Q4 2019 in Review

Advisor Group reduced its Tandem Diabetes Care (TNDM) stake by 56% in Q4 2019, selling an estimated $120K and leaving 1,507 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Advisor Group first reported a position in TNDM in Q1 2017 and has held it in 12 quarters since. The position peaked at $1.12M in Q1 2019. 284 funds tracked by Wall St. Rank hold TNDM as of Q4 2019.

Advisor Group held 1,507 shares of Tandem Diabetes Care worth $89K as of Q4 2019.
Advisor Group sold 1,942 Tandem Diabetes Care shares in Q4 2019, an estimated $120K.
Tandem Diabetes Care made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3023 holding.
Advisor Group first reported a position in Tandem Diabetes Care in Q1 2017 and has held it in 12 quarters since.
Advisor Group's Tandem Diabetes Care position peaked at $1.12M in Q1 2019.
284 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.